Nagehan Emiralioglu is an expert in Pediatrics at Hacettepe University (Turkey). As of October 2026, ScienceLeadR ranks Nagehan Emiralioglu in the top 1% of experts worldwide for Congenital Abnormalities, and in the top 1% of experts in Turkey for Pancreatic Diseases and Cardiovascular Abnormalities. Nagehan Emiralioglu has authored 262 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 1 of them ongoing. SLR score: 695 (community average: 125). How the SLR is computed.

LeadR Profile

Nagehan Emiralioglu Hacettepe University Turkey
695 ScienceLeadR Reputation 695
Network Map

Pediatrics

Subspecialties: Pulmonology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2014 - 2026

Source: PubMed

Hacettepe University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 262

Citations

Citations: 1 351 1st author: 33 Last author: 4 Unique author: 1


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Adverse Events Associated with CFTR Modulator Therapy: Experience from a Tertiary Care Center.
PMID 42826236 — tertiary care centers, fibrosis, exanthema, drug-related side effects and adverse reactions, cystic fibrosis, therapeutics, tertiary healthcare, child
Turk Arch Pediatr20260
Pleuroparenchymal Fibroelastosis in Children: A Rare Interstitial Lung Disease with Distinct Features.
PMID 42826243 — lung, lung diseases, child, lung diseases, interstitial
Turk Arch Pediatr20260
Association between insulin resistance and obstructive sleep apnea in non-diabetic children with obesity.
PMID 42722762 — insulin resistance, insulin, sleep apnea, obstructive, sleep, apnea, polysomnography, obesity, sex, sleep apnea syndromes, pediatrics, child
Eur J Pediatr20260
Interstitial Lung Disease in Children: Rare Genetic Variants Beyond Surfactant Dysfunction.
PMID 42598967 — registries, genes, lung, respiratory system, diagnosis, therapeutics, pediatrics, lung diseases, steroids, child, lung diseases, interstitial
Pediatr Pulmonol20260
Clinical features associated with Pseudomonas aeruginosa colonization in children under 2 years of age: a retrospective study of Cystic Fibrosis Registry.
PMID 42497434 — registries, fibrosis, retrospective studies, pseudomonas, pseudomonas aeruginosa, cystic fibrosis, pediatrics, child
Turk J Pediatr20260

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2 Study Chair: 1

By phase:

N/A 5
Phase 2 1

By status:

Recruiting 3
Completed 2
Terminated 1

By type:

Observational 5
Interventional 1

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 1
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Comparison of Symptoms Pulmonary Function Muscle Strength Exercise Capacity and Frailty Level in Individuals With Esophageal Atresia and Healthy Individuals
NCT06975982 — exercise, quality of life, muscles, esophagus, esophageal atresia, signs and symptoms, muscle strength, posture, frailty, cough, child
N/ARecruiting2024

LeadR Networks

Main global connection map